Topics and FacultyIntroduction and Program OverviewJanice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and Director of Pharmacy, PinnacleHealth, Harrisburg, PA

Primer on Medication Administration Systems and Medications Used in RadiologyLior Molvin, (MBA) (RT) (R) (CT), CT Protocol Technologist, CT Protocol Development and Education Team, Stanford University Medical Center and Stanford Medicine, Imaging Center, Palo Alto, CA

Medication Safety Issues and Recommended Strategies Matthew P. Fricker, Jr, MS, RPh, FASHP, Program Director, ISMP

Centers for Medicare & Medicaid Services (CMS) and The Joint Commission Requirements Darryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist, ISMP

Question and Answer SessionJanice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and Director of Pharmacy, PinnacleHealth, Harrisburg, PA

This CE activity is funded through an educational grant from Bracco Diagnostics.

Institute for Safe Medication Practices (ISMP) 200 Lakeside Drive, Suite 200, Horsham, PA 19044 Phone: (215) 947-7797 www.ismp.org

For registration questions, contact ProCE at 1-800-748-7795.

Activity DescriptionRadiology departments often use medications in ways that are different from other clinical areas of the hospital, and staff may not be aware of the significant safety issues that can arise. This webinar will explore current medication safety issues in the radiology setting, such as the safe use of contrast, appropriate labeling of containers, beyond-use dating, and patient identification. Nationally known experts will discuss actual cases in which errors have occurred, and will describe risk-reduction strategies, including use of technology and best practices. Faculty will also discuss an Imaging Bulk Package for contrast recently approved by the US Food and Drug Administration, as well as regulatory and Joint Commission accreditation requirements for use of contrast and other medications in radiology.

Learning ObjectivesThe target audience for this activity includes pharmacists and radiologic technologists. At the completion of this activity, the participant should be able to:• Describe how medications and contrast agents are ordered, stored, prepared, and utilized

in the radiology setting.• Explain the difference between the new FDA classification of an imaging bulk package vs.

a pharmacy bulk package of contrast, and why FDA developed this new product type. • Identify system-based causes of medication errors associated with the use of medications

and contrast agents in radiology.• Prioritize selected strategies to prevent harm and improve medication safety in radiology.• Describe current regulatory and accreditation requirements related to the use of medications

and contrast agents in radiology, and the role of the pharmacy in assuring compliance with the standards.

AccreditationPharmacists: This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-15-089-H05-P has been assigned to this knowledge-based, home-study activity.

This CE activity is approved for 2.0 contact hours (0.20 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.

Radiologic Technologists: Approved by the ASRT for Category A continuing education credit.

Improving Medication Safety in the Radiology SettingThis CE activity is available as an On-Demand Webinar at www.ProCE.com/Radiology

CE CREDIT OPPORTUNITY:

ON-DEMAND WEBINAR

Release Date: June 15, 2015

Expiration Date: June 15, 2018